Steroid and surfactant mix fails to impact bronchopulmonary dysplasia in preterm infants

Research led by the Royal Women’s Hospital, Australia, has found that early intratracheal administration of budesonide mixed with surfactant may have little to no effect on improving survival free of bronchopulmonary dysplasia (BPD) in extremely preterm infants.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup